…
Horizon Technology Finance Corporation is a business development company specializing in lending and and investing in development-stage investments. It focuses on making secured debt and venture lending investments to venture capital backed companies in the technology, life science, healthcare information and services, cleantech and sustainability industries. It seeks to invest in companies in the United States.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Horizon Technology Finance is a Nasdaq-listed business development company that provides debt and structured financing to venture-backed technology and life sciences companies. Long-term growth may be supported by interest income from floating-rate loans, potential upside from equity co-investments and warrants, and continued deal flow in innovation sectors, making the company a potential source of income and private-market exposure for investors.
Key risks include credit losses and illiquidity from lending to growth-stage firms, valuation volatility of equity stakes, leverage and regulatory constraints on BDCs, and sensitivity to interest-rate and capital-market conditions.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -1.60M | -4.16M | -15.70M | 21.87M | 28.18M |
| Net income | -2.66M | -5.63M | -17.18M | 21.15M | 27.78M |
| Selling general administrative | 6.00M | 5.84M | 5.67M | 4.78M | 4.69M |
| Gross profit | 7.22M | 1.69M | -9.87M | 26.64M | 33.27M |
| Ebit | - | -4.16M | 103.85M | 56.10M | -5.08M |
| Ebitda | -1.60M | -4.16M | -15.70M | 41.07M | 28.18M |
| Depreciation and amortization | - | - | -91.91M | - | 45.30M |
| Operating income | -1.60M | -4.16M | -15.70M | 41.07M | 28.18M |
| Other operating expenses | 41.62M | 38.10M | 34.80M | 4.78M | 5.08M |
| Interest expense | 32.80M | 32.26M | 28.97M | 19.20M | 12.03M |
| Tax provision | 1.06M | 1.48M | 1.49M | 0.71M | 0.40M |
| Interest income | 90.46M | 96.97M | 110.13M | 77.37M | 54.41M |
| Net interest income | 57.66M | 64.71M | 81.16M | 58.16M | 42.38M |
| Income tax expense | 1.06M | 1.48M | 1.49M | 0.71M | 0.40M |
| Total revenue | 40.02M | 33.94M | 19.10M | 26.64M | 33.27M |
| Total operating expenses | 8.82M | 5.84M | 5.82M | 4.78M | 5.08M |
| Cost of revenue | 32.80M | 32.26M | 28.97M | - | - |
| Total other income expense net | -35.62M | -32.26M | -107.60M | -19.20M | -12.03M |
| Net income from continuing ops | -2.66M | -5.63M | -17.18M | 21.15M | 27.78M |
| Net income applicable to common shares | - | - | - | 21.15M | 27.78M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 811.10M | 821.83M | 802.36M | 766.83M | 513.96M |
| Other current assets | - | 3.34M | -89.65M | 2.79M | 1.36M |
| Total liab | 492.60M | 485.65M | 478.38M | 448.38M | 268.62M |
| Total stockholder equity | 318.50M | 336.18M | 323.98M | 318.45M | 245.34M |
| Other current liab | -15.05M | 17.75M | -58.94M | -9.16M | -6.37M |
| Common stock | 0.05M | 0.04M | 0.04M | 0.03M | 0.02M |
| Capital stock | 0.05M | 0.04M | 0.04M | 0.03M | 0.02M |
| Retained earnings | -240.90M | -182.06M | -127.00M | -67.50M | -56.05M |
| Other assets | - | 735.01M | 802.36M | 5.55M | 3.81M |
| Cash | 105.52M | 70.26M | 73.08M | 20.61M | 38.05M |
| Total current liabilities | 95.17M | 17.75M | 58.94M | 9.16M | 6.37M |
| Net debt | 367.51M | 397.64M | 389.15M | 413.47M | 219.56M |
| Short term debt | 95.17M | 63.82M | 47.93M | - | - |
| Short long term debt total | 473.03M | 467.90M | 462.24M | 434.08M | 257.61M |
| Other stockholder equity | 559.36M | 518.20M | 450.95M | 385.92M | 301.36M |
| Total current assets | 117.61M | 90.16M | 63.20M | 34.19M | 44.21M |
| Long term investments | 681.96M | 725.16M | 735.53M | 727.09M | 465.94M |
| Net tangible assets | - | - | - | 318.45M | 245.34M |
| Short term investments | - | -27.27M | 2.64M | - | 458.07M |
| Net receivables | 12.09M | 16.56M | 13.93M | 13.57M | 6.15M |
| Inventory | - | - | 0.00M | - | - |
| Accounts payable | 15.05M | 13.16M | 11.01M | 9.16M | 6.37M |
| Accumulated other comprehensive income | - | 0.00M | 0.00M | - | - |
| Non currrent assets other | 46.26M | 6.51M | -709.09M | -727.09M | -465.94M |
| Non current assets total | 693.50M | 731.67M | 739.16M | 727.09M | 465.94M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Change to liabilities | - | - | - | -0.39M | -1.29M |
| Total cashflows from investing activities | 16.67M | -35.70M | -55.33M | - | - |
| Net borrowings | 31.42M | 6.08M | 26.68M | 179.07M | 72.62M |
| Total cash from financing activities | -14.80M | 21.21M | 50.51M | 229.46M | 75.52M |
| Change to operating activities | - | - | - | -4.11M | -0.35M |
| Net income | -2.66M | -5.63M | -17.18M | 21.15M | 27.78M |
| Change in cash | 41.83M | 24.45M | 45.26M | -16.82M | -0.48M |
| Begin period cash flow | 100.87M | 73.08M | 30.47M | 47.28M | 47.76M |
| End period cash flow | 142.69M | 97.53M | 75.72M | 30.47M | 47.28M |
| Total cash from operating activities | 56.63M | 39.64M | 50.07M | -246.28M | -75.99M |
| Issuance of capital stock | 14.08M | 66.35M | 65.09M | 84.60M | 30.09M |
| Depreciation | 2.65M | 1.78M | 1.85M | 1.60M | 1.09M |
| Other cashflows from investing activities | 234.45M | 182.06M | - | - | - |
| Dividends paid | 53.09M | 46.37M | 40.52M | -29.85M | -24.55M |
| Change to account receivables | 0.69M | -0.92M | 1.77M | -3.42M | -0.17M |
| Other cashflows from financing activities | -7.21M | -4.85M | -0.73M | 352.14M | 181.85M |
| Change to netincome | - | - | - | -261.11M | -103.04M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | 3.04M | -6.31M | -4.62M | -7.92M | -1.82M |
| Other non cash items | 53.60M | 51.58M | 71.88M | -261.11M | -103.04M |
| Free cash flow | 56.63M | 39.64M | 50.07M | -246.28M | -75.99M |
Sector: Financial Services Industry: Asset Management
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| HRZN Horizon Technology Finance |
-0.13 3.28% |
3.83 | 13.40 | 6.28 | 3.27 | 0.79 | 35.64 | 13.46 |
| BLK BlackRock Inc |
33.95 2.88% |
1212.82 | 26.25 | 19.57 | 6.33 | 2.90 | 6.35 | 17.13 |
| BX Blackstone Group Inc |
4.89 4.09% |
124.39 | 33.20 | 20.12 | 11.05 | 11.56 | 9.14 | 15.74 |
| IVSBF Investor AB ser. B |
-1.61 3.64% |
42.50 | 4.67 | 3.83 | 3.78 | 1.13 | 4.15 | 1.68 |
| KKR KKR & Co. Inc. |
1.83 1.90% |
98.31 | 32.68 | 13.66 | 3.58 | 3.22 | 0.68 | 1.47 |
Horizon Technology Finance Corporation is a business development company specializing in lending and and investing in development-stage investments. It focuses on making secured debt and venture lending investments to venture capital backed companies in the technology, life science, healthcare information and services, cleantech and sustainability industries. It seeks to invest in companies in the United States.
312 Farmington Avenue, Farmington, CT, United States, 06032
860 674 9977
| Name | Title | Year Born |
|---|---|---|
| Mr. Robert D. Pomeroy Jr. | Chairman & CEO | 1951 |
| Mr. Gerald A. Michaud | Pres & Director | 1952 |
| Mr. Daniel R. Trolio CPA | Exec. VP, CFO & Treasurer | 1973 |
| Mr. Daniel S. Devorsetz C.F.A., CFA | Exec. VP, Chief Investment Officer & COO | 1970 |
| Ms. Megan N. Bacon | Director of Investor Relations & Marketing | NA |
| Mr. John C. Bombara | Exec. VP, Gen. Counsel, Sec. & Chief Compliance Officer | 1964 |
| Mr. Kevin T. Walsh | Sr. Managing Director of Technology - West Coast | NA |
| Mr. Todd A. McDonald | Sr. Managing Director of Technology ? Mid-Atlantic, Southeast | NA |
| Mr. Mishone B. Donelson | Managing Director of Life Science ? East Coast | NA |
| Mr. Kevin J. May | Sr. Managing Director of West Coast | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.